CN101085314A - 一种治疗月经后期的中成药 - Google Patents
一种治疗月经后期的中成药 Download PDFInfo
- Publication number
- CN101085314A CN101085314A CN 200710117855 CN200710117855A CN101085314A CN 101085314 A CN101085314 A CN 101085314A CN 200710117855 CN200710117855 CN 200710117855 CN 200710117855 A CN200710117855 A CN 200710117855A CN 101085314 A CN101085314 A CN 101085314A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- rhizoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 230000003111 delayed effect Effects 0.000 title claims description 20
- 230000005906 menstruation Effects 0.000 title description 5
- 230000027758 ovulation cycle Effects 0.000 claims description 21
- 241000218176 Corydalis Species 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000157835 Gardenia Species 0.000 claims description 7
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 230000036407 pain Effects 0.000 description 18
- 229940079593 drug Drugs 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗月经后期的中成药,它是以香附、郁金、丹参和乌药等10多味中草药为原料。具有活血止痛,理气调经的功效。本发明是在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。本发明的目的是提供一种治疗月经后期的中成药。具有疗效确切、安全方便、无毒副作用、价格低廉的特点。
Description
技术领域
本发明涉及一种治疗月经后期的中成药,是一种治疗月经后期以中草药为原料的中成药。属于中药领域。
背景技术
月经病是指凡月经的周期、经期和经量发生异常,以及伴随月经周期出现明显不适症状,或于绝经前后所出现的有关的一系列症状为特征的一类疾病。月经周期错后7天以上,甚至错后3~5个月一行,经期正常者,称为“月经后期”。亦称“经期错后”,“经迟”。本病相当于西医学的月经稀发。月经后期如伴经量过少,常可发展为闭经。主要发病机理是精血不足或邪气阻滞,血海不能按时满溢,遂致月经后期。中医在临床上分为肾虚型,血虚型,虚寒证,实寒证,气滞型,痰湿型等症型辨证治疗,取得很好效果。发明一种既安全又有效的中药制剂,具有重大意义。
发明内容
本发明是在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。本发明的目的是提供一种治疗月经后期的中成药。具有疗效确切、安全方便、无毒副作用、价格低廉的特点。
本发明是由下述重量配比的原料制成的:
香附 1.5~6份 木香 1.0~4份 牡丹皮 1.0~4份
郁金 1.5~6份 当归 1.0~4份 柴 胡 0.1~2份
丹参 1.5~6份 栀子 1.0~4份 延胡索 0.1~2份
乌药 1.0~4份 桃仁 1.0~4份 川 芎 0.1~2份。
本发明的优选配方各原料的重量配比是:
香附 2.5~3.5份 木香 1.5~2.5份 牡丹皮 1.5~2.5份
郁金 2.5~3.5份 当归 1.5~2.5份 柴 胡 0.5~1.5份
丹参 2.5~3.5份 栀子 1.5~2.5份 延胡索 0.5~1.5份
乌药 1.5~2.5份 桃仁 1.5~2.5份 川 芎 0.5~1.5份。
本发明的最佳配方各原料的重量配比是:
香附3份 木香2份 牡丹皮2份
郁金3份 当归2份 柴 胡1份
丹参3份 栀子2份 延胡索1份
乌药2份 桃仁2份 川 芎1份。
本发明中的药物机理如下:
香附 药性辛、甘、微苦,平。归肝、三焦经。具有理气解郁,调经,安胎的功效。可治疗胁肋胀痛,乳房胀痛,疝气疼痛,月经不调,脘腹痞满疼痛,嗳气吞酸,呕恶,经行腹痛,崩漏带下,胎动不安等。(《中药大辞典》南京中医药大学编著 上海科学技术出版社第二版第2341页)。
郁金药性辛、苦,寒。归心、肝、胆经。具有活血止痛,行气解郁,清心凉血,利胆的功效。可治疗胸腹胁肋诸痛,痛经,癥瘕,热病神昏,癫狂,吐血,衄血,血淋,砂淋,黄疸等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第1855页)。
丹参药性苦,微寒。归心、心包、肝经。具有活血祛瘀,调经止痛,除烦安神,凉血消痈的功效。可治疗妇女月经不调,痛经,经闭,产后瘀滞腹痛,心腹疼痛,癥瘕积聚,热痹肿痛,跌打损伤,热入营血,烦燥不安,心烦失眠,痈疮肿毒等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第647页)。
乌药 药性辛,温。归脾、胃、肝、肾、膀胱经。具有行气止痛,温肾散寒的功效。可治疗胸胁满闷,脘腹胀痛,头痛,寒疝疼痛,痛经及产后腹痛,尿频,遗尿等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第655页)。
木香 药性辛、苦,温。归脾、胃、肝、肺经。具有行气止痛,调和导滞的功效。可治疗胸胁胀满,脘腹胀痛,呕吐泄泻,痢疾后重等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第480页)。
当归 药性甘、辛、苦,温。归肝、心、脾经。具有补血活血,调经止痛,润燥滑肠的功效。可治疗血虚诸证,月经不调,经闭,痛经,癥瘕结聚,崩漏,虚寒腹痛,痿痹,肌肤麻木,肠燥便难,赤痢后重,痈疽疮疡,跌扑损伤等。(《中药大辞典》 南京中医药大学编著 上海科学技术出版社第二版第1210页)。
栀子药性苦,寒。归心、肝、肺、胃、三焦经。具有泻火除烦,清热利湿,凉血解毒的功效。可治疗热病心烦,肝火目赤,头痛,湿热黄疸,淋症,吐血,衄血,血痢,尿血,口舌生疮,疮疡肿毒,扭伤肿痛等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第2242页)。
桃仁 药性苦、甘,小毒。归心、肝、大肠经。具有活血祛瘀,润肠通便的功效。可治疗痛经,血滞经闭,产后瘀滞腹痛,癥瘕结块,跌打损伤,瘀血肿痛,肺痈,肠痈,肠燥便秘等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第2542页)。
牡丹皮药性苦、辛,微寒。归心、肝、肾经。具有清热凉血,活血散瘀的功效。可治疗温热病热入血分,发斑,吐衄,热病后期热伏阴分发热,骨蒸潮热,血滞经闭,痛经,癥瘕,痈肿疮毒,跌扑伤痛,风湿痹痛等。(《中药大辞典》南京中医药大学编著 上海科学技术出版社第二版第1578页)。
柴胡性味苦、微寒。归肝、胆经。具有和解表里、疏肝、升阳的功效。可治疗寒热往来、胸满胁痛、耳聋、头痛目眩、疟疾、下痢脱肛、月经不调、子宫下垂、感冒、上呼吸道感染、肝炎、胆囊炎等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第1004页)。
延胡索药性辛、苦,温。归心、肝、脾经。具有活血散瘀,行气止痛的功效。可治疗胸痹心痛,脘腹疼痛,腰痛,疝气痛,痛经,经闭,癥瘕,产后瘀滞腹痛,跌打损伤等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第1261页)。
川芎 药性辛,温。归肝、胆、心包经。具有活血祛瘀,行气开郁,祛风止痛的功效。可治疗月经不调,经闭痛经,产后瘀滞腹痛,癥瘕肿块,胸胁疼痛,头痛眩晕,风寒湿痹,跌打损伤,痈疽疮疡等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第292页)。
本发明遵循中医“君臣佐使”的组方原则,用香附、郁金和丹参为君药;用乌药、木香、当归、栀子、桃仁和牡丹皮为臣药;用柴胡、延胡索和川芎为佐使药。诸药相合,共具活血止痛,理气调经的功效。治疗月经后期具有疗效确切,无毒副作用,服用方便,价格低廉的特点。
本发明药物临床使用结果表明,有如下优点:
1、本发明选用的中草药各组份符合中华人民共和国药典的规定,利用各味中药的综合作用治疗月经后期,对人体无毒无害。经动物急、慢性毒性实验表明被实验的动物未见任何毒性反应,其主要脏器也无明显的改变,药物安全可靠。
2、本发明药中富含蛋白质,葡萄糖,葡萄糖醛酸,挥发油,果胶,果糖,有机酸,卵磷脂,维生素,氨基酸,还含皂甙,植物甾醇和钙等多种微量元素,利于人体吸收,增强体质。
3、本发明不仅可有效的治疗月经后期,对月经后期的预防也有很好的作用,治疗月经后期具有疗效确切,无毒副作用,服用方便,价格低廉的特点。
为表明本发明药物对治疗月经后期的治疗效果,经临床试验结果如下;治疗月经后期患者13例。服用实施例汤剂,每次1袋,一日二至三次,饭前半小时服用。三个月为一个疗程,连续服用三个疗程观察疗效。痊愈8例占61.54%,好转3例占23.08%,未愈2例占15.38%,总有效率达84.62%。经三个疗程治疗后,病人无任何不良反应,三大常规化验及肝肾功能检测未发现异常。
具体实施方式
实施例 汤剂 按下述重量称取原料:
香附3份 木香2份 牡丹皮2份
郁金3份 当归2份 柴 胡1份
丹参3份 栀子2份 延胡索1份
乌药2份 桃仁2份 川 芎1份
制备方法是取上述原料洗净去杂,晾干,粉碎成颗粒,加水浸泡1小时,置多功能提取罐中加水煎煮二次,第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过。第二次加总药材7倍量的水,煎煮1~1.2小时,取两次煎液,滤过,热封袋中,105℃高温灭菌,包装即得。本发明制成的治疗月经后期的汤剂为塑封袋装,每袋210ml,口服,一次一袋,每日二至三次。三个月为一个疗程。
Claims (3)
1、一种治疗月经后期的中成药,其特征在于它是由下述重量配比的原料制成的:
香附1.5~6份 木香1.0~4份 牡丹皮1.0~4份
郁金1.5~6份 当归1.0~4份 柴 胡0.1~2份
丹参1.5~6份 栀子1.0~4份 延胡索0.1~2份
乌药1.0~4份 桃仁1.0~4份 川 芎0.1~2份。
2、根据权利要求1所述的一种治疗月经后期的中成药,其中各原料的重量配比是:
香附2.5~3.5份 木香1.5~2.5份 牡丹皮1.5~2.5份
郁金2.5~3.5份 当归1.5~2.5份 柴 胡0.5~1.5份
丹参2.5~3.5份 栀子1.5~2.5份 延胡索0.5~1.5份
乌药1.5~2.5份 桃仁1.5~2.5份 川 芎0.5~1.5份。
3、根据权利要求1所述的一种治疗月经后期的中成药,其中各原料的重量配比是:
香附3份 木香2份 牡丹皮2份
郁金3份 当归2份 柴 胡1份
丹参3份 栀子2份 延胡索1份
乌药2份 桃仁2份 川 芎1份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710117855 CN101085314A (zh) | 2007-06-26 | 2007-06-26 | 一种治疗月经后期的中成药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710117855 CN101085314A (zh) | 2007-06-26 | 2007-06-26 | 一种治疗月经后期的中成药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101085314A true CN101085314A (zh) | 2007-12-12 |
Family
ID=38936599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200710117855 Pending CN101085314A (zh) | 2007-06-26 | 2007-06-26 | 一种治疗月经后期的中成药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101085314A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166311A (zh) * | 2010-11-19 | 2011-08-31 | 李德儒 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
| CN102793884A (zh) * | 2012-09-05 | 2012-11-28 | 山东省中医药研究院 | 一种治疗痛经的中药贴膏及其制备方法 |
| CN104840867A (zh) * | 2015-04-17 | 2015-08-19 | 金科 | 一种治疗气滞型月经后期的中药组合物 |
| CN105477619A (zh) * | 2016-01-22 | 2016-04-13 | 王浩 | 一种治疗月经后期的中药组合物 |
| CN105998514A (zh) * | 2016-06-04 | 2016-10-12 | 陈福平 | 用于调理内分泌失调的中药 |
-
2007
- 2007-06-26 CN CN 200710117855 patent/CN101085314A/zh active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166311A (zh) * | 2010-11-19 | 2011-08-31 | 李德儒 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
| CN102166311B (zh) * | 2010-11-19 | 2012-03-07 | 吴光龙 | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 |
| CN102793884A (zh) * | 2012-09-05 | 2012-11-28 | 山东省中医药研究院 | 一种治疗痛经的中药贴膏及其制备方法 |
| CN102793884B (zh) * | 2012-09-05 | 2014-01-29 | 山东省中医药研究院 | 一种治疗痛经的中药贴膏及其制备方法 |
| CN104840867A (zh) * | 2015-04-17 | 2015-08-19 | 金科 | 一种治疗气滞型月经后期的中药组合物 |
| CN105477619A (zh) * | 2016-01-22 | 2016-04-13 | 王浩 | 一种治疗月经后期的中药组合物 |
| CN105998514A (zh) * | 2016-06-04 | 2016-10-12 | 陈福平 | 用于调理内分泌失调的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129723A (zh) | 治疗便秘的一种中药制剂 | |
| CN101085314A (zh) | 一种治疗月经后期的中成药 | |
| CN101129766A (zh) | 一种治疗便秘的中药制剂 | |
| CN101129988A (zh) | 一种治疗产后恶露不绝的中药制剂 | |
| CN101085143A (zh) | 一种治疗痛经的中药组合 | |
| CN101129627A (zh) | 一种治疗产后邪毒发热的中药制剂 | |
| CN101066320A (zh) | 一种治疗经行风疹块的中药组合 | |
| CN101129529A (zh) | 一种治疗产后血瘀发热的中药制剂 | |
| CN101085140A (zh) | 一种治疗月经先期的药物 | |
| CN101066429A (zh) | 一种治疗经行乳房胀痛的中药 | |
| CN101085249A (zh) | 一种治疗月经先期的中药 | |
| CN101085281A (zh) | 治疗慢性肾炎的一种中药 | |
| CN101085335A (zh) | 一种治疗痛经的中药汤剂 | |
| CN101085313A (zh) | 一种治疗倒经的中药制剂 | |
| CN101085311A (zh) | 一种治疗经行情志异常的中药组合 | |
| CN101129938A (zh) | 治疗输卵管炎的一种中药制剂 | |
| CN101028406B (zh) | 一种治疗痛经的中药汤剂 | |
| CN101095919A (zh) | 一种治疗糖尿病性胆结石的中成药 | |
| CN101095922A (zh) | 一种治疗糖尿病性末梢神经炎的中药组合物 | |
| CN101095772A (zh) | 一种治疗糖尿病性疖肿的中药制剂 | |
| CN101095913A (zh) | 治疗糖尿病性胆囊炎的一种中药制剂 | |
| CN101129897A (zh) | 一种治疗子宫内膜炎的中成药 | |
| CN101085312A (zh) | 一种治疗甲亢的中药 | |
| CN101049474A (zh) | 一种治疗子宫发育不良性不孕症的中药制剂 | |
| CN101129881A (zh) | 一种治疗乳房带状疱疹的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071212 |